Novus Biologicals™ CD9 Antibody (Genentech patent anti-CD9) - Humanized, Novus Biologicals™
Human Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
CD9
Applications
Flow Cytometry, ELISA, Functional Assay
Conjugate
Unconjugated
Host Species
Human
Research Discipline
Cancer, Stem Cell Markers
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias
BA2, BA-2/p24 antigen, BTCC-1, CD9 antigen, CD9 molecule, Cell growth-inhibiting gene 2 protein, DRAP-27, Leukocyte antigen MIC3, motility related protein-1,5H9 antigen, Motility-related protein, MRP-1FLJ99568, P24, Tetraspanin-29, TSPAN-29, TSPAN29MIC3CD9 antigen (p24)
Immunogen
CD9
Primary or Secondary
Primary
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone
Genentech patent anti-CD9
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Target Species
Human
Gene Accession No.
P21926
Gene ID (Entrez)
928
Isotype
IgG1
Purification Method
Protein A purified
Content And Storage
Store at -20°C in powder form. Store at -80°C once reconstituted.
Related Products
Description
- CD9 Monoclonal antibody specifically detects CD9 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay